Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00870519 · ClinicalTrials.gov registry record · Phase 1

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

A Phase 1 study, sponsored by Institute for Neurodegenerative Disorders.

Terminated
Registry status
Phase 1
Development phase
2
Enrollment target

NCT00870519: Clinical Trial Phase 1 study, sponsored by Institute for Neurodegenerative Disorders.

NCT00870519 is a Phase 1 study that was terminated before completion, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00870519, a Phase 1 study, was terminated before completion, sponsored by Institute for Neurodegenerative Disorders.

TERMINATED
Registry status
Phase 1
Development phase
2 participants
Enrollment target

Study Summary

The underlying goal of this study is to assess 123-I MNI-168 SPECT imaging as a tool to detect ß-amyloid deposition in the brain of Alzheimer's Disease (AD) research participants and similarly aged and gender matched healthy subjects.

Interventions

  • DRUG I-123-MNI-168
  • DRUG 123-I MNI-168

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2009-01
Est. Completion 2010-12
Phase Phase 1

Why NCT00870519 stopped before completion

NCT00870519 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which I-123-MNI-168 is the first listed.

NCT00870519 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00870519 about?

NCT00870519 is a clinical study titled "Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects". The underlying goal of this study is to assess 123-I MNI-168 SPECT imaging as a tool to detect ß-amyloid deposition in the brain of Alzheimer's Disease (AD) research participants and similarly aged and gender matched healthy subjects.

What is the current status of trial NCT00870519?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00870519?

The interventions under investigation include: I-123-MNI-168 (DRUG), 123-I MNI-168 (DRUG).

Who is sponsoring clinical trial NCT00870519?

This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00870519's enrollment target sits among peer trials

2 2000th of 2000 the lowest of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00870519, the US trial registry maintained by the National Library of Medicine. NCT00870519 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.